Sylvia Franc

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Venues

Diabetes, obesity & metabolism

Diabetes care

Diabetes technology & therapeutics

JMIR research protocols

CEntre for study and Research for Improvement of the Treatment of Diabetes (CERITD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

CEntre for study and Research for Improvement of the Treatment of Diabetes (CERITD)

France

Research director :: Diabetes

Sud Francilien Hospital

France

Hospital Practitioner :: Diabetes

Publications

Gregg D Simonson, Amy B Criego, Tadej Battelino, Anders L Carlson, Pratik Choudhary, Sylvia Franc, Dana Gershenoff, George Grunberger, Irl B Hirsch, Diana Isaacs, Mary L Johnson, David Kerr, Davida F Kruger, Chantal Mathieu, Thomas W Martens, Revital Nimri, Sean M Oser, Anne L Peters, Tracey D Brown, Eugene E Wright, Carol H Wysham, Richard M Bergenstal
Expert Panel Recommendations for a Standardized Ambulatory Glucose Profile Report for Connected Insulin Pens. Diabetes technology & therapeutics (2024)
Sarah Meulebrouck, Victoria Scherrer, Raphaël Boutry, Bénédicte Toussaint, Emmanuel Vaillant, Aurélie Dechaume, Hélène Loiselle, Beverley Balkau, Guillaume Charpentier, Sylvia Franc, Michel Marre, Morgane Baron, Martine Vaxillaire, Mehdi Derhourhi, Mathilde Boissel, Phillippe Froguel, Amélie Bonnefond
Pathogenic monoallelic variants in GLIS3 increase type 2 diabetes risk and identify a subgroup of patients sensitive to sulfonylureas. Diabetologia (2023)
Pierre Yves Benhamou, Alice Adenis, Hocine Lebbad, Yousra Tourki, Maria-Belen Heredia, Bernhard Gehr, Sylvia Franc, Guillaume Charpentier
One year real-world performance of the DBLG1 closed-loop system: Data from 3706 adult users with type 1 diabetes in Germany. Diabetes, obesity & metabolism (2023)
Pierre Yves Benhamou, Alice Adenis, Hocine Lebbad, Yousra Tourki, Maria-Belen Heredia, Bernhard Gehr, Sylvia Franc, Guillaume Charpentier
One-year real-world performance of the DBLG1 closed-loop system: Data from 3706 adult users with type 1 diabetes in Germany. Diabetes, obesity & metabolism (2023)
Pierre Yves Benhamou, Sandrine Lablanche, Anne Vambergue, Sylvie Pou, Stéphanie Madrolle, Hector Romero-Ugalde, Sylvia Franc, Guillaume Charpentier
The beneficial effects of closed-loop insulin delivery in patients with highly unstable type 1 diabetes eligible for islet transplantation are maintained over 6 months: An extension study of the DBLHU-WP10 trial. Diabetes, obesity & metabolism 24 (5) (2022)
Pierre Yves Benhamou, Stéphanie Madrolle, Sandrine Lablanche, Alexandre Gallegos, Yousra Tourki, Sylvia Franc, Maeva Doron, Guillaume Charpentier
Comment on Leelarathna et al. Duration of Hybrid Closed-Loop Insulin Therapy to Achieve Representative Glycemic Outcomes in Adults With Type 1 Diabetes. Diabetes Care 2020;43:e38-e39. Diabetes care 43 (10) (2021)
Coralie Amadou, Sylvia Franc, Pierre-Yves Benhamou, Sandrine Lablanche, Erik Huneker, Guillaume Charpentier, Alfred Penfornis, null null
Diabeloop DBLG1 Closed-Loop System Enables Patients With Type 1 Diabetes to Significantly Improve Their Glycemic Control in Real-Life Situations Without Serious Adverse Events: 6-Month Follow-up. Diabetes care 44 (3) (2021)
Sylvia Franc, Pierre Yves Benhamou, Sophie Borot, Lucy Chaillous, Brigitte Delemer, Maeva Doron, Bruno Guerci, Hélène Hanaire, Erik Huneker, Nathalie Jeandidier, Coralie Amadou, Pr Eric Renard, Yves Reznik, Pauline Schaepelynck, Chantal Simon, Charles Thivolet, Claire Thomas, Patrick Hannaert, Guillaume Charpentier
No more hypoglycaemia on days with physical activity and unrestricted diet when using a closed-loop system for 12 weeks: A post hoc secondary analysis of the multicentre, randomized controlled Diabeloop WP7 trial. Diabetes, obesity & metabolism 23 (9) (2021)
Pierre Yves Benhamou, Sandrine Lablanche, Anne Vambergue, Maeva Doron, Sylvia Franc, Guillaume Charpentier
Patients with highly unstable type 1 diabetes eligible for islet transplantation can be managed with a closed-loop insulin delivery system: A series of N-of-1 randomized controlled trials. Diabetes, obesity & metabolism 23 (1) (2020)
Sylvia Franc, Michael Joubert, Ahmed Daoudi, Cédric Fagour, Pierre-Yves Benhamou, Michel Rodier, Beatrix Boucherie, Eric Benamo, Pauline Schaepelynck, Bruno Guerci, Dured Dardari, Sophie Borot, Alfred Penfornis, Geneviève D'Orsay, Karine Mari, Yves Reznik, Caroline Randazzo, Guillaume Charpentier, null null
Efficacy of two telemonitoring systems to improve glycaemic control during basal insulin initiation in patients with type 2 diabetes: The TeleDiab-2 randomized controlled trial. Diabetes, obesity & metabolism 21 (10) (2019)
Nathalie Jeandidier, Lucy Chaillous, Sylvia Franc, Pierre Yves Benhamou, Pauline Schaepelynck, Hélène Hanaire, Bogdan Catargi, Anne Farret, Pierre Fontaine, Bruno Guerci, Yves Reznik, Alfred Penfornis, Sophie Borot, Pierre Serusclat, Yacine Kherbachi, Geneviève D'Orsay, Bruno Detournay, Pierre Simon, Guillaume Charpentier
DIABEO App Software and Telemedicine Versus Usual Follow-Up in the Treatment of Diabetic Patients: Protocol for the TELESAGE Randomized Controlled Trial. JMIR research protocols 7 (4) (2018)

Sylvia Franc.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Sylvia Franc